United States · FDA National Drug Code directory
Cefoxitin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 63323-341_9f457501-b963-49c0-89a3-4228eb493895
- Product NDC
- 63323-341
- Form
- POWDER, FOR SOLUTION
- Composition / generic term
- Cefoxitin Sodium
- Labeler
- Fresenius Kabi USA, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20110706
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFOXITIN SODIUM — 1 g/1
These values do not establish equivalence or a dose recommendation.
Packages
- 25 VIAL in 1 CARTON (63323-341-25) / 1 POWDER, FOR SOLUTION in 1 VIAL (63323-341-01) · 63323-341-25
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →